Press Releases

December 8, 2022

Alto Neuroscience Presents New Data Leveraging EEG and Machine Learning to Predict Individual Response to Antidepressants at the 61st Annual Meeting of the American College of Neuropsychopharmacology

November 15, 2022

Alto Neuroscience Wins 2022 BioTech Breakthrough and BioSpace’s 2023 Best Places to Work Awards

October 25, 2022

Alto Neuroscience Announces $35 Million Series B Financing

September 16, 2022

Alto Neuroscience to Participate in the Cowen 2nd Annual Novel Mechanisms in Neuropsychiatry Summit

May 12, 2022

Alto Neuroscience CEO, Amit Etkin, M.D., Ph.D., Appointed to NIDA’s National Advisory Council on Drug Abuse (NACDA)

April 12, 2022

Industry Veteran Mikael Eliasson, M.D., Ph.D., Joins Alto Neuroscience as Chief Operating Officer

December 16, 2021

Cerebral and Alto Neuroscience Enter into Strategic Collaboration to Launch First-Ever Decentralized Study in Precision Psychiatry

November 11, 2021

Alto Neuroscience Announces Publication in Nature Neuroscience Highlighting Superiority of Data-Driven Framework for Mapping Human Neurobiology Domains

October 14, 2021

Alto Neuroscience Emerges with Largest Clinical-Stage Precision Psychiatry Pipeline and $40 Million in Financing

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Receive updates from Alto

Thanks for signing up!

Oops! Something went wrong while submitting the form.

© Alto Neuroscience 2022